The devil in the details: Thorough assessment of evidence and ethics is needed in evaluating new HIV prevention methods

American Journal of Bioethics

Volumn 12, Issue 6, 2012, Pages 33-34

  Dawson, Liza ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; EQUIPOISE; ETHICS; FEMALE; HEALTH CARE DELIVERY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIMARY PREVENTION; RESEARCH ETHICS;

ANTI-HIV AGENTS; ETHICS, RESEARCH; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PRIMARY PREVENTION; THERAPEUTIC EQUIPOISE;

EID: 84865654805     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265161.2012.672621     Document Type: Article

References (5)

1. Byar, D. P., D. A. Schoenfeld, S. B. Green, et al. 1990. Design considerations for AIDS trials. New England Journal of Medicine 323: 1343-1348.
2. Epstein, S. 1996. Impure science: AIDS, activism, and the politics of knowledge. Berkeley: University of California Press.
3. Haire, B., J. Kaldor, and C. F. Jordens. 2012. How good is "good enough"? The case for varying standards of evidence according to need for new interventions in HIV prevention. American Journal of Bioethics 12(6): 21-30.
4. Merigan, T. C. 1990. You can teach an old dog new tricks. How AIDS trials are pioneering new strategies. New England Journal of Medicine 323: 1341-1343.
5. Padian, N. S., S. I. McCoy, S. S. A. Karim et al. 2011. HIV prevention transformed: The new prevention research agenda. Lancet 378(9787): 269-278.